1. Home
  2. MYND vs IPSC Comparison

MYND vs IPSC Comparison

Compare MYND & IPSC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • MYND
  • IPSC
  • Stock Information
  • Founded
  • MYND 1998
  • IPSC 2019
  • Country
  • MYND United States
  • IPSC United States
  • Employees
  • MYND N/A
  • IPSC N/A
  • Industry
  • MYND Other Consumer Services
  • IPSC Medicinal Chemicals and Botanical Products
  • Sector
  • MYND Real Estate
  • IPSC Health Care
  • Exchange
  • MYND Nasdaq
  • IPSC Nasdaq
  • Market Cap
  • MYND 42.3M
  • IPSC 49.6M
  • IPO Year
  • MYND 2017
  • IPSC 2021
  • Fundamental
  • Price
  • MYND $0.86
  • IPSC $0.56
  • Analyst Decision
  • MYND
  • IPSC Strong Buy
  • Analyst Count
  • MYND 0
  • IPSC 5
  • Target Price
  • MYND N/A
  • IPSC $3.33
  • AVG Volume (30 Days)
  • MYND 12.2K
  • IPSC 942.0K
  • Earning Date
  • MYND 03-26-2025
  • IPSC 08-07-2025
  • Dividend Yield
  • MYND N/A
  • IPSC N/A
  • EPS Growth
  • MYND N/A
  • IPSC N/A
  • EPS
  • MYND N/A
  • IPSC N/A
  • Revenue
  • MYND $267,380,999.00
  • IPSC $114,898,000.00
  • Revenue This Year
  • MYND N/A
  • IPSC $1,064.82
  • Revenue Next Year
  • MYND N/A
  • IPSC N/A
  • P/E Ratio
  • MYND N/A
  • IPSC N/A
  • Revenue Growth
  • MYND N/A
  • IPSC 8286.72
  • 52 Week Low
  • MYND $0.61
  • IPSC $0.34
  • 52 Week High
  • MYND $3.89
  • IPSC $3.29
  • Technical
  • Relative Strength Index (RSI)
  • MYND 56.43
  • IPSC 48.22
  • Support Level
  • MYND $0.81
  • IPSC $0.55
  • Resistance Level
  • MYND $1.00
  • IPSC $0.60
  • Average True Range (ATR)
  • MYND 0.10
  • IPSC 0.04
  • MACD
  • MYND 0.00
  • IPSC -0.00
  • Stochastic Oscillator
  • MYND 73.68
  • IPSC 15.96

About MYND Mynd.ai Inc.

Mynd.ai Inc is a company that provides a platform for delivering digital content in K-12 classrooms, giving teachers seamless connectivity to inspire young minds. It features agnostic hardware that integrates across technology providers. Its product line includes a wide range of interactive tools and technologies, with its award-winning interactive displays at the forefront. It also offers interactive software apps such as Screen Share, computing modules, and accessories that meet the needs of customers, including K -12 educators, colleges and universities, small businesses and corporations, government agencies, and more. Geographically, it operates in United States and Rest of the world.

About IPSC Century Therapeutics Inc.

Century Therapeutics Inc is a biotechnology company that specializes in leveraging adult stem cells to develop cell therapy products aimed at treating cancer, autoimmune disorders, and inflammatory diseases. Their features a genetically engineered allogeneic cell therapy platform that incorporates induced pluripotent stem cells (iPSCs), CRISPR-mediated precision gene editing, proprietary chimeric antigen receptors (CARs), Allo-EvasionTM technology, and manufacturing capabilities. This comprehensive platform seeks to address the limitations of first-generation cell therapies by optimizing cell product performance, preventing rejection by the host immune system, and reducing development and supply risks.

Share on Social Networks: